← Back to Search

Reach For Health Program for Delaying Sexual Activity in Children

Phase 2
Waitlist Available
Led By Lydia O'Donnell, Ed.D.
Research Sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial will develop and evaluate strategies to reduce early sexual activity and risky sexual behavior in middle school-aged children in Brooklyn, NY. These strategies will focus on parent education, classroom health curriculum, and community service.

Who is the study for?
This trial is for middle school-aged children and their parents in NYC schools that are implementing the 'Reach For Health' program. Participants must be enrolled in general education classes and capable of completing surveys in English.Check my eligibility
What is being tested?
The study is testing strategies to reduce early sexual activity among children by using parent education, a classroom health curriculum, and community service participation as part of the 'Reach For Health' program.See study design
What are the potential side effects?
Since this trial involves educational programs rather than medical interventions, there are no direct physical side effects. However, participants may experience changes in knowledge, attitudes, or behaviors regarding sexual activity.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Lead Sponsor
1,953 Previous Clinical Trials
2,659,359 Total Patients Enrolled
Lydia O'Donnell, Ed.D.Principal InvestigatorEducation Development Center, Inc.
1 Previous Clinical Trials
3,660 Total Patients Enrolled

Media Library

Treatment Clinical Trial Eligibility Overview. Trial Name: NCT00059241 — Phase 2
Sexual Activity Research Study Groups:
Sexual Activity Clinical Trial 2023: Treatment Highlights & Side Effects. Trial Name: NCT00059241 — Phase 2
Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT00059241 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is eligibility for this trial restricted to persons over 65 years of age?

"This medical trial has an eligibility criteria of age 10-14, inclusively."

Answered by AI

Are there any openings for this scientific endeavor?

"Presently, clinicaltrials.gov does not list this investigation as actively recruiting participants. Initially posted on July 1st 2000 and last updated June 23rd 2005, the trial is no longer seeking patients; however, a plethora of analogous studies are accepting volunteers at present."

Answered by AI

What potential health hazards could patients be exposed to through this treatment?

"A rating of 2 is assigned to this treatment due to the fact that it's in Phase 2, meaning there exists some data attesting to its safety but none providing evidence for efficacy."

Answered by AI

To what extent is this experiment open to the public?

"This medical experiment is enrolling 1200 minors aged between 10 and 14 with existing sexual behaviour. Furthermore, applicants are required to be associated with the Reach for Health program in New york City schools and attending mainstream education classes."

Answered by AI
~49 spots leftby Mar 2025